A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Stopped A business decision was made to discontinue further enrollment. There were no safety concerns that contributed to this decision.
Conditions
- Advanced Solid Tumor
- Non-small Cell Lung Cancer
- Colorectal Cancer
- Squamous Cell Carcinoma
- Ovarian Carcinoma
- Peritoneal Carcinoma
- Fallopian Tube Cancer
- Head and Neck Squamous Cell Carcinoma
- Triple Negative Breast Cancer
Interventions
Sponsor
Numab Therapeutics AG